Aptevo Therapeutics files prospectus supplement for up to $2.3 million stock offering
Alpha Vantage · Investing.com India · · AI-summarised by FinFlash
Aptevo Therapeutics Inc. announced it has filed a prospectus supplement with the SEC to offer and sell up to $2.3 million of its common stock. The offering will be conducted under an existing At The Market Offering Agreement with Roth Capital Partners, LLC. The company had previously sold 303,157 shares under this agreement, generating Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context